Tamoxifen in the rat prevents estrogen-deficiency bone loss elicited with the LHRH agonist buserelin
- 1 August 1992
- journal article
- Published by Elsevier in Bone and Mineral
- Vol. 18 (2) , 143-152
- https://doi.org/10.1016/0169-6009(92)90854-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Preventive effects of clomiphene citrate on estrogen-deficiency osteopenia elicited by LHRH agonist administration in the ratJournal of Bone and Mineral Research, 1991
- Tamoxifen as a Potential Preventive Agent in Healthy Postmenopausal WomenJNCI Journal of the National Cancer Institute, 1990
- A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and compositionJournal of Endocrinology, 1989
- Bone mineral density in women with breast cancer treated with adjuvant tamoxifen for at least two yearsBreast Cancer Research and Treatment, 1988
- Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma CellsScience, 1988
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Effects of anti-estrogens on bone in castrated and intact female ratsBreast Cancer Research and Treatment, 1987
- Hypogonadism induced by luteinising hormone releasing hormone agonist analogues: effects on bone density in premenopausal women.BMJ, 1987
- LHRH ANALOGUES AND BONE LOSSThe Lancet, 1987
- BONE FORMATION AND RESORPTION AS THE DETERMINANTS OF TRABECULAR BONE VOLUME IN POSTMENOPAUSAL OSTEOPOROSISThe Lancet, 1981